hrs4r
 I want to donate
Firma
XAVIER ALDEGUER-MANTE
Position
Cap de Grup - R4
Group leader - R4

Projectes

Codi oficial: La Marató 201912-31 Start date:30/09/2020 Data fi: 30/09/2023 Investigador/a principal: XAVIER ALDEGUER MANTE Organisme finançador: FUNDACIO LA MARATO TV3 Ajuda: 199,812.50 €

Publicacions

0

Eradication of neoplastic Barrett's esophagus in patients with esophageal varices with a modified endoscopic mucosal resection technique and radiofrequency ablation.

Endoscopy, 2022, 54, 261-263 dx.doi.org/10.1055/a-1516-3400

Oliveras B, Albert M, López C, Fort E, Peries L, Gutiérrez L, Busquets D, Uchima H, Aldeguer X, Piñol V

A case report of gastrointestinal histoplasmosis in a patient treated with infliximab.

Clinical Journal of Gastroenterology, 2021, 14, 690-692 dx.doi.org/10.1007/s12328-020-01298-y

Garre-Olmo J, Turró-Garriga O, Martí-Lluch R, Zacarías-Pons L, Alves-Cabratosa L, Serrano-Sarbosa D, Vilalta-Franch J, Ramos R

Changes in lifestyle resulting from confinement due to COVID-19 and depressive symptomatology: A cross-sectional a population-based study.

COMPREHENSIVE PSYCHIATRY, 2021, 104, 152214-152214 dx.doi.org/10.1016/j.comppsych.2020.152214

Oliver L, Ramió-Pujol S, Amoedo J, Malagón M, Serrano M, Bahí A, Lluansí A, Torrealba L, Busquets D, PARDO, L., Serra-Pagès M, Aldeguer X, Garcia-Gil J

A Novel Grape-Derived Prebiotic Selectively Enhances Abundance and Metabolic Activity of Butyrate-Producing Bacteria in Faecal Samples.

FRONTIERS IN MICROBIOLOGY, 2021, 12, 639948-639948 dx.doi.org/10.3389/fmicb.2021.639948

Lluansí A, Llirós M, Oliver L, Bahí A, Elias-Masiques N, Gonzalez M, Benejam P, Cueva E, Termes M, Ramió-Pujol S, Malagón M, Amoedo J, Serrano M, Busquets D, Torreabla L, Sabat M, Buxó M, Cambra M, Serra-Pagès M, Delgado-Aros S, García-Gil LJ, Elias I, Aldeguer X

In vitro Prebiotic Effect of Bread-Making Process in Inflammatory Bowel Disease Microbiome.

FRONTIERS IN MICROBIOLOGY, 2021, 12, 716307-716307 dx.doi.org/10.3389/fmicb.2021.716307
0

RAID Prediction: Pilot Study of Fecal Microbial Signature With Capacity to Predict Response to Anti-TNF Treatment.

INFLAMMATORY BOWEL DISEASES, 2021, 27, 63-66 dx.doi.org/10.1093/ibd/izab273
0

Effectiveness and Safety of Ustekinumab in Ulcerative Colitis: Real-world Evidence from the ENEIDA Registry.

JOURNAL OF CROHNS & COLITIS, 2021, 15, 1846-1851 dx.doi.org/10.1093/ecco-jcc/jjab070

Lopez-Siles M, Aldeguer X, Sabat-Mir M, Serra-Pagès M, Duncan SH, Flint HJ, Garcia-Gil LJ, Martinez-Medina M

Evaluation of bacterial biomarkers to aid in challenging inflammatory bowel diseases diagnostics and subtype classification.

World Journal Of Gastrointestinal Pathophysiology, 2020, 11, 64-77 dx.doi.org/10.4291/wjgp.v11.i3.64

Casanova MJ, Chaparro M, Mínguez M, Ricart E, Taxonera C, García-López S, Guardiola J, López-San Román A, Iglesias E, Beltrán B, Sicilia B, Vera MI, Hinojosa J, Riestra S, Domènech E, Calvet X, Pérez-Calle JL, Martín-Arranz MD, Aldeguer X, Rivero M, Monfort D, Barrio J, Esteve M, Márquez L, Lorente R, García-Planella E, de Castro L, Bermejo F, Merino O, Rodríguez-Pérez A, Martínez-Montiel P, Van Domselaar M, Alcaín G, Domínguez-Cajal M, Muñoz C, Gomollón F, Fernández-Salazar L, García-Sepulcre MF, Rodríguez-Lago I, Gutiérrez A, Argüelles-Arias F, Rodriguez C, Rodríguez GE, Bujanda L, Llaó J, Varela P, Ramos L, Huguet JM, Almela P, Romero P, Navarro-Llavat M, Abad Á, Ramírez-de la Piscina P, Lucendo AJ, Sesé E, Madrigal RE, Charro M, García-Herola A, Pajares R, Khorrami S, Gisbert JP

Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients With Inflammatory Bowel Disease: Results From the Eneida Registry.

INFLAMMATORY BOWEL DISEASES, 2020, 26, 606-616 dx.doi.org/10.1093/ibd/izz192

Marin-Jimenez I, Bastida G, Forés A, Garcia-Planella E, Argüelles-Arias F, Sarasa P, Tagarro I, Fernández-Nistal A, Montoto C, Aguas M, Santos-Fernández J, Bosca-Watts MM, Ferreiro R, Merino O, Aldeguer X, Cortés X, Sicilia B, Mesonero F, Barreiro-de Acosta M

Impact of comorbidities on anti-TNFa response and relapse in patients with inflammatory bowel disease: the VERNE study.

BMJ Open Gastroenterology, 2020, 7 dx.doi.org/10.1136/bmjgast-2019-000351

Propietat intel·lectual

Xavier Aldeguer Mante

METHOD FOR DIAGNOSING COLORECTAL CANCER FROM A HUMAN FECES SAMPLE BY QUANTITIVE PCR, PRIMERS AND KIT

Número de publicació: WO2015132273 Data de publicació: 2015-09-11

Xavier Aldeguer Mante

METHOD FOR THE QUANTIFICATION OF FAECALIBACTERIUM PRAUSNITZII PHYLOGROUP I AND/OR PHYLOGROUP II MEMBERS AND THE USE THEREOF AS BIOMARKERS

Número de publicació: WO2017025617 Data de publicació: 2017-02-16

Formulari de contacte

About IDIBGI!

menu